GlassScriptPhysician profile
Leda Gattoc
NPI 1073751731
$6,514.59
in general payments reported to CMS, 2019-2025
37 companies · $1,634 in 2025
The $1,634 reported for 2025 was more than what 76% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $215 · 2021: $257 · 2022: $2,055 · 2023: $758 · 2024: $1,463 · 2025: $1,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,790 · Education: $51.40 · Gift: $14.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,789.50 |
| Education | $51.40 |
| Gift | $14.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,861.77 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $927.11 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Glaxosmithkline, LLC. | $582.66 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Eisai INC. | $550.11 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $539.89 | 2019-2025 | Lynparza, Tagrisso, Enhertu |
| Smith+Nephew, INC. | $386.96 | 2023-2025 | Grafix, Stravix |
| Pfizer INC. | $148.18 | 2023-2025 | |
| Daiichi Sankyo INC. | $146.04 | 2024-2025 | Enhertu, Datroway |
| Novartis Pharmaceuticals Corporation | $116.17 | 2023-2024 | |
| Seagen INC. | $103.40 | 2022-2023 | Tukysa, Adcetris |
| Coherus Oncology, INC. | $94.43 | 2022-2024 | |
| Myriad Genetic Laboratories, INC. | $90.64 | 2021-2024 | Mychoice Cdx |
| Genentech USA, INC. | $85.46 | 2024-2025 | Tecentriq, Rozlytrek, Alecensa |
| Astellas Pharma US INC | $80.83 | 2024 | Veozah |
| Alexion Pharmaceuticals, INC. | $70.96 | 2024-2025 | Ultomiris |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $70.60 | 2019-2025 | Vistaseal, Surgiflo Hemostatic Matrix, Surgicel Nu-Knit |
| Jazz Pharmaceuticals INC. | $62.68 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.90 | 2024 | Fruzaqla, Alunbrig |
| Karyopharm Therapeutics INC. | $50.86 | 2022-2025 | Xpovio |
| Caris Mpi, INC. | $50.03 | 2025 | Mi Cancer Seek |
| Servier Pharmaceuticals LLC | $49.81 | 2024 | |
| Janssen Biotech, INC. | $44.56 | 2022-2025 | Rybrevant, Erleada |
| Immunogen, INC. | $42.94 | 2023 | Elahere |
| Exelixis INC. | $31.35 | 2025 | Cabometyx |
| Conmed Corporation | $29.43 | 2023 | Airseal |
| Iovance Biotherapeutics, INC. | $26.32 | 2025 | Amtagvi |
| Regeneron Healthcare Solutions, INC. | $26.00 | 2025 | Lynozyfic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.65 | 2022 | |
| Blue Earth Diagnostics | $22.75 | 2022 | |
| Springworks Therapeutics, INC. | $21.39 | 2025 | Gomekli |
| Davol INC. | $20.65 | 2024 | Arista Ah Flexitip |
| Bayer Healthcare Pharmaceuticals INC. | $17.76 | 2023 | |
| Mimedx Group, INC. | $17.28 | 2025 | |
| Solventum Corporation | $16.08 | 2024 | Prevena |
| Baxter Healthcare | $15.46 | 2023 | Floseal |
| Tesaro, INC. | $14.30 | 2019 | |
| Meditrina | $14.18 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leda Gattoc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.